Condition (MeSH)
Visceral Pain
ClinicalTrials.gov lists 53 trials for Visceral Pain or a narrower condition beneath it. Cara Therapeutics, Inc. has the most among industry and government lead sponsors, with 2.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
53 of the 53 trials are tagged with Visceral Pain itself; the rest are tagged with a narrower condition beneath it.
When did Visceral Pain trials start? (22)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 7
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 5 |
| 2025 | 7 |
| 2024 | 2 |
| 2023 | 4 |
| 2022 | 1 |
| 2021 | 3 |
| 2020 | 4 |
| 2019 | 2 |
| 2018 | 4 |
| 2017 | 1 |
Showing 10 of 22 earlier years.
No forecast is made for this condition: it averages 3.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Prediction, not a registry value: median of 32 months from start to primary completion across 6 trials still running at the 2026-10-09 snapshot; registered median of 13 months across 34 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Visceral Pain trials in? (6)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 5 |
| Phase 3 | 3 |
| Phase 4 | 10 |
| Not applicable | 29 |
| Observational | 4 |
How many Visceral Pain trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 5 |
| Recruiting | 6 |
| Completed | 32 |
| Terminated | 2 |
| Withdrawn | 2 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Visceral Pain trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Cara Therapeutics, Inc. | 2 |
Which drugs are being tested for Visceral Pain? (4)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Oxycodone | 3 |
| Dronabinol | 2 |
| CR845 | 2 |
| Butorphanol | 2 |
Interventions as named in the registry (11)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| PO Morphine | 3 |
| High-dose anrikefon | 2 |
| Medium-dose anrikefon | 2 |
| Low-dose anrikefon | 2 |
| Paravertebral Block | 1 |
Showing 5 of 11 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Visceral Pain trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Mental Status Changes | 2 | 1 |
| Sedation | 2 | 2 |
| Anaemia Postoperative | 1 | 1 |
| Blood Sodium Increased | 1 | 1 |
| Cerebral Infarction | 1 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Visceral Pain? (50)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Comparison of hyperbaric bupivacaine with fentanyl vs. hyperbaric bupivacaine with dexmedetomidine in reducing visceral pain during cesarean delivery under spinal anesthesia: study protocol. | Pain management | 2025 | Yes |
| Esketamine Combined with Dexmedetomidine to reduce Visceral Pain During elective Cesarean Section Under Combined Spinal-Epidural Anesthesia: A double-Blind Randomized Controlled Study. | Drug design, development and therapy | 2024 | Yes |
| The Role of Sex Hormones in Pain-Related Conditions. | International journal of molecular sciences | 2023 | Yes |
| Effect of butorphanol on visceral pain in patients undergoing gastrointestinal endoscopy: a randomized controlled trial. | BMC anesthesiology | 2023 | Yes |
| Paragastric Autonomic Neural Blockade to Prevent Early Visceral Pain and Associated Symptoms After Laparoscopic Sleeve Gastrectomy: a Randomized Clinical Trial. | Obesity surgery | 2022 | Yes |
Showing 5 of 50 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.